HealthEquity (NASDAQ:HQY) Price Target Raised to $110.00 at Wells Fargo & Company

HealthEquity (NASDAQ:HQY – Get Free Report) had its target price increased by equities researchers at Wells Fargo & Company from $107.00 to $110.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target points to a potential upside […]

Leave a Reply

Your email address will not be published.

Previous post Government Borrowing in May Reaches Post-Covid Peak
Next post Taysha Gene Therapies (NASDAQ:TSHA) Rating Reiterated by Cantor Fitzgerald